Jay Venkatesan

Insider Reports History

Entity
Individual
Location
C/O Ayer Capital Management, Lp, 230 California St, Suite 600, San Francisco, CA
Signature
/s/ Jay Venkatesan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jay Venkatesan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 2.6M $33.1M $12.74 Jul 15, 2022 By Alpine ImmunoSciences, L.P.
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 238K $3.03M $12.74 Jul 15, 2022 Direct
Elicio Therapeutics, Inc. Director Pre-Funded Warrants 50K $250K $4.99 Jun 28, 2024 Direct
Elicio Therapeutics, Inc. Director Pre-Funded Warrants 50K $250K $4.99 Jun 28, 2024 Indirect
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 18.6K $237K $12.74 Jul 15, 2022 By Raj Venkatesan as UTMA custodian for Nathaniel Graham Venkatesan
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 18.6K $237K $12.74 Jul 15, 2022 By Raj Venkatesan as UTMA custodian for Reid Coleman Venkatesan
Elicio Therapeutics, Inc. Director Common Stock 180K $1.8K $0.01 Nov 26, 2024 Direct
Elicio Therapeutics, Inc. Director Common Stock 953 $9.53 $0.01 Nov 26, 2024 By Trust
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Stock Option (Right to buy) 70K Jul 15, 2022 Direct
Elicio Therapeutics, Inc. Director Common Warrants 50K Jun 28, 2024 Direct
Elicio Therapeutics, Inc. Director Common Warrants 50K Jun 28, 2024 Indirect
Elicio Therapeutics, Inc. Director Stock Option (Right to Buy) 4.1K Nov 21, 2024 Direct
Elicio Therapeutics, Inc. Director Warrant to Purchase Common Stock 0 Nov 26, 2024 Direct

Insider Reports Filed by Jay Venkatesan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELTX Elicio Therapeutics, Inc. Nov 26, 2024 2 $500 4 Nov 29, 2024 Director
ELTX Elicio Therapeutics, Inc. Nov 21, 2024 1 $0 4 Nov 25, 2024 Director
ELTX Elicio Therapeutics, Inc. Jun 28, 2024 8 $998K 4 Jul 2, 2024 Director
ELTX Elicio Therapeutics, Inc. Dec 28, 2023 1 $0 4 Dec 29, 2023 Director
ALPN ALPINE IMMUNE SCIENCES, INC. Jul 15, 2022 2 $0 4 Jul 19, 2022 Director, 10%+ Owner
ELTX Angion Biomedica Corp. May 25, 2022 1 $14.1K 4 May 27, 2022 Officer, Director
ELTX Angion Biomedica Corp. May 20, 2022 2 $101K 4 May 25, 2022 President and Chief Executive Officer and Director, Director
ELTX Angion Biomedica Corp. Mar 3, 2022 2 $0 4 Mar 4, 2022 President and Chief Executive Officer
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 3, 2022 1 $0 4 Jan 4, 2022 Director, 10%+ Owner
ELTX Angion Biomedica Corp. Dec 27, 2021 2 $730K 4 Dec 29, 2021 President and Chief Executive Officer and Director, Director
ELTX Angion Biomedica Corp. Dec 20, 2021 1 $8.98K 4 Dec 22, 2021 President and Chief Executive Officer and Director, Director
ELTX Angion Biomedica Corp. Dec 16, 2021 2 $106K 4 Dec 20, 2021 President and Chief Executive Officer and Director, Director
ALPN ALPINE IMMUNE SCIENCES, INC. Sep 17, 2021 1 -$3.76M 4 Sep 21, 2021 Director, 10%+ Owner
ELTX Angion Biomedica Corp. Jun 24, 2021 2 -$379K 4 Dec 17, 2021 President and Chief Executive Officer and Director, Director
ELTX Angion Biomedica Corp. Feb 9, 2021 4 $4.59K 4/A May 27, 2022 President and Chief Executive Officer and Director, Director